243 related articles for article (PubMed ID: 32620030)
1. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
[TBL] [Abstract][Full Text] [Related]
3. 3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3.
Wik JA; Lundbäck P; la Cour Poulsen L; Haraldsen G; Skålhegg BS; Hol J
PLoS One; 2020; 15(3):e0229395. PubMed ID: 32130250
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
[TBL] [Abstract][Full Text] [Related]
5. The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.
Emini Veseli B; Van Wielendaele P; Delibegovic M; Martinet W; De Meyer GRY
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073144
[TBL] [Abstract][Full Text] [Related]
6. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
[TBL] [Abstract][Full Text] [Related]
7. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.
Schoors S; De Bock K; Cantelmo AR; Georgiadou M; Ghesquière B; Cauwenberghs S; Kuchnio A; Wong BW; Quaegebeur A; Goveia J; Bifari F; Wang X; Blanco R; Tembuyser B; Cornelissen I; Bouché A; Vinckier S; Diaz-Moralli S; Gerhardt H; Telang S; Cascante M; Chesney J; Dewerchin M; Carmeliet P
Cell Metab; 2014 Jan; 19(1):37-48. PubMed ID: 24332967
[TBL] [Abstract][Full Text] [Related]
8. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
Tian W; Guo HS; Li CY; Cao W; Wang XY; Mo D; Hao XW; Feng YD; Sun Y; Lei F; Zhang HN; Zhao MG; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 368():26-36. PubMed ID: 30776389
[TBL] [Abstract][Full Text] [Related]
9. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
[TBL] [Abstract][Full Text] [Related]
10. 3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells.
Kotowski K; Supplitt S; Wiczew D; Przystupski D; Bartosik W; Saczko J; Rossowska J; Drąg-Zalesińska M; Michel O; Kulbacka J
Anticancer Res; 2020 May; 40(5):2613-2625. PubMed ID: 32366406
[TBL] [Abstract][Full Text] [Related]
11. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
[TBL] [Abstract][Full Text] [Related]
12. In vitro angiogenesis inhibition with selective compounds targeting the key glycolytic enzyme PFKFB3.
Abdali A; Baci D; Damiani I; Belloni F; De Dominicis C; Gelmi ML; Corsini A; Bellosta S
Pharmacol Res; 2021 Jun; 168():105592. PubMed ID: 33813027
[TBL] [Abstract][Full Text] [Related]
13. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
Klarer AC; O'Neal J; Imbert-Fernandez Y; Clem A; Ellis SR; Clark J; Clem B; Chesney J; Telang S
Cancer Metab; 2014 Jan; 2(1):2. PubMed ID: 24451478
[TBL] [Abstract][Full Text] [Related]
15. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
16. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
17. Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice.
Burmistrova O; Olias-Arjona A; Lapresa R; Jimenez-Blasco D; Eremeeva T; Shishov D; Romanov S; Zakurdaeva K; Almeida A; Fedichev PO; Bolaños JP
Sci Rep; 2019 Aug; 9(1):11670. PubMed ID: 31406177
[TBL] [Abstract][Full Text] [Related]
18. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
[TBL] [Abstract][Full Text] [Related]
19. PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.
Cao Y; Zhang X; Wang L; Yang Q; Ma Q; Xu J; Wang J; Kovacs L; Ayon RJ; Liu Z; Zhang M; Zhou Y; Zeng X; Xu Y; Wang Y; Fulton DJ; Weintraub NL; Lucas R; Dong Z; Yuan JX; Sullivan JC; Meadows L; Barman SA; Wu C; Quan J; Hong M; Su Y; Huo Y
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13394-13403. PubMed ID: 31213542
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3.
Lea MA; Guzman Y; Desbordes C
Anticancer Res; 2016 Apr; 36(4):1479-88. PubMed ID: 27069123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
